ERC Investigators

Since the European Research Council (ERC) launched in 2007, many innovative and ambitious projects by EMBL scientists have been awarded financial support by the ERC.

The ERC promotes frontier research by outstanding scientists and selects projects based solely on scientific excellence.

During their time at EMBL, the following scientists have been awarded funding across the three ERC core grant schemes: starting, consolidator and advanced grants.

Find out more about the ERC.

Advanced Grants

headshot of Eileen Furlong

Eileen Furlong

DeCRyPT 2019 – 2023

Deciphering Cis-Regulatory Principles of Transcriptional regulation: Combining large-scale genetics and genomics to dissect functional principles of genome regulation during embryonic development

headshot of Lars Steinmetz

Lars Steinmetz

SystGeneEdit 2017 – 2022

Dissecting quantitative traits and their underlying genetic interactions via systematic genome editing

Consolidator Grants

headshot of Miki Ebisuya

Miki Ebisuya

ALLOCHRONY 2020 – 2025

Quantitative Investigation of Interspecies Differences in Developmental Tempo

headshot of Jan Korbel

Jan Korbel

MOSAIC 2019 – 2024

Relationship of Somatic Structural Variation Mosaicism to Aging and Disease Phenotypes

headshot of Robert Prevedel

Robert Prevedel

Brillouin4Life 2020 – 2025

Development of advanced optical tools for studying cellular mechanics at high spatial and temporal resolution

headshot of Judith Zaugg

Judith Zaugg

epiNicheAML 2022 – 2027

Mechanistic models of leukemia-niche interaction using multimodal single-cell profiling

Starting Grants

headshot of Tina Haase

Tina Haase

3DVasCMD 2022 – 2027

Development of novel 3D vascularized cardiac models to investigate Coronary Microvascular Disease

headshot of Michael Zimmermann

Michael Zimmermann

GutTransForm 2023 – 2028

Gut microbiota drug biotransformation as a tool to unravel the mechanisms of metabolic microbiota-host interactions

Synergy Grants

Proof of Concept Grants

photo of Theodore Alexandrov

Theodore Alexandrov

METADRUG 2022 – 2023

Single-Cell Metabolomics for Drug Discovery and Development

EMBL has a long-standing tradition of scientific excellence that builds on highly interactive research Units and takes pride in the level of collaborative work engaged in by its Groups and Teams, involving both EMBL-internal and external collaborators.